423 related articles for article (PubMed ID: 20108773)
1. [Detection and the production mechanism of antinuclear antibodies (ANA) and anti-liver/kidney microsomal tpe 1 antibodies (anti-LKM1) in patients with chronic hepatitis C].
Bai L; Lu HY; Feng ZR; Yu M; Li WG; Gong WB; Zhao NE; Xu XY
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Aug; 23(4):278-81. PubMed ID: 20108773
[TBL] [Abstract][Full Text] [Related]
2. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].
Wu CH; Xu XY; Tian GS; Yu YY
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):390-3. PubMed ID: 16677548
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of antinuclear and anti-liver-kidney-microsome type-1 antibodies in patients with chronic hepatitis C in China.
Bai L; Feng ZR; Lu HY; Li WG; Yu M; Xu XY
Chin Med J (Engl); 2009 Jan; 122(1):5-9. PubMed ID: 19187609
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
[TBL] [Abstract][Full Text] [Related]
5. Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile.
Cassani F; Cataleta M; Valentini P; Muratori P; Giostra F; Francesconi R; Muratori L; Lenzi M; Bianchi G; Zauli D; Bianchi FB
Hepatology; 1997 Sep; 26(3):561-6. PubMed ID: 9303483
[TBL] [Abstract][Full Text] [Related]
6. Antinuclear antibody is associated with a more advanced fibrosis and lower RNA levels of hepatitis C virus in patients with chronic hepatitis C.
Hsieh MY; Dai CY; Lee LP; Huang JF; Tsai WC; Hou NJ; Lin ZY; Chen SC; Wang LY; Chang WY; Chuang WL; Yu ML
J Clin Pathol; 2008 Mar; 61(3):333-7. PubMed ID: 17545561
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies in chronic hepatitis C virus infection and their association with disease profile.
Williams MJ; Lawson A; Neal KR; Ryder SD; Irving WL;
J Viral Hepat; 2009 May; 16(5):325-31. PubMed ID: 19302340
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic accuracy of atypical p-ANCA in autoimmune hepatitis using ROC- and multivariate regression analysis.
Terjung B; Bogsch F; Klein R; Söhne J; Reichel C; Wasmuth JC; Beuers U; Sauerbruch T; Spengler U
Eur J Med Res; 2004 Sep; 9(9):439-48. PubMed ID: 15546809
[TBL] [Abstract][Full Text] [Related]
9. Antineutrophil cytoplasmic antibody in patients with antinuclear antibody-positive chronic hepatitis C.
Ohira H; Tojo J; Shinzawa J; Suzuki T; Miyata M; Nishimaki T; Kasukawa R
Fukushima J Med Sci; 1998 Dec; 44(2):83-92. PubMed ID: 10091380
[TBL] [Abstract][Full Text] [Related]
10. Serological markers of autoimmunity in patients infected with hepatitis C virus: impact of HIV co-infection.
Adeyemi OM; Attar B; Jensen D; Ghaoui R; Cotler SJ
HIV Med; 2005 Nov; 6(6):371-4. PubMed ID: 16268816
[TBL] [Abstract][Full Text] [Related]
11. Anti-C-reactive protein antibodies in chronic hepatitis C infection: correlation with severity and autoimmunity.
Kessel A; Elias G; Pavlotzky E; Zuckerman E; Rosner I; Toubi E
Hum Immunol; 2007 Oct; 68(10):844-8. PubMed ID: 17961773
[TBL] [Abstract][Full Text] [Related]
12. [A prospective study on the prevalence and clinical significance of autoantibodies in patients with suspected nonalcoholic fatty liver disease].
Cho DH; Choi MS; Kim DH; Kim DY; Shim SG; Lee JH; Koh KC; Paik SW; Yoo BC; Rhee JC
Korean J Hepatol; 2005 Sep; 11(3):261-7. PubMed ID: 16177552
[TBL] [Abstract][Full Text] [Related]
13. Antinuclear antibody positivity in patients with chronic hepatitis C: clinically relevant or an epiphenomenon?
Narciso-Schiavon JL; Freire FC; Suarez MM; Ferrari MV; Scanhola GQ; Schiavon Lde L; Carvalho Filho RJ; Ferraz ML; Silva AE
Eur J Gastroenterol Hepatol; 2009 Apr; 21(4):350-6. PubMed ID: 20611005
[TBL] [Abstract][Full Text] [Related]
14. [Autoimmune hepatitis and/or hepatitis C].
Simonović J; Dokić Lj; Svirtlih N; Djordjević M; Bozić N; Poluga J
Srp Arh Celok Lek; 1999; 127(3-4):109-13. PubMed ID: 10500434
[TBL] [Abstract][Full Text] [Related]
15. [Autoantibodies in chronic hepatitis C. Markers of autoimmunity or non-specific events?].
Vella FS; Orlando P; Attanasi F; Simone B; Mundo A; Lopalco P; Schiraldi O; Antonaci S
Recenti Prog Med; 2001 Feb; 92(2):107-12. PubMed ID: 11294098
[TBL] [Abstract][Full Text] [Related]
16. Antinuclear antibodies (ANA) in chronic hepatitis C virus infection: correlates of positivity and clinical relevance.
Yee LJ; Kelleher P; Goldin RD; Marshall S; Thomas HC; Alberti A; Chiaramonte M; Braconier JH; Hall AJ; Thursz MR
J Viral Hepat; 2004 Sep; 11(5):459-64. PubMed ID: 15357653
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies in chronic liver disease.
Ghonaim M; Al-Ghamdi A; El-Bana H; Bakr A; Ghoneim E; El-Edel R; Hassona M; Shoeib S; Allam H
Egypt J Immunol; 2005; 12(2):101-11. PubMed ID: 17977215
[TBL] [Abstract][Full Text] [Related]
18. Antinuclear antibody positivity in patients with chronic hepatitis C: clinically relevant or an epiphenomenon?
Narciso-Schiavon JL; Freire FC; Suarez MM; Ferrari MV; Scanhola GQ; Schiavon Lde L; de Carvalho Filho RJ; Ferraz ML; Silva AE
Eur J Gastroenterol Hepatol; 2009 Apr; 21(4):440-6. PubMed ID: 19382301
[TBL] [Abstract][Full Text] [Related]
19. Anti-ENA antibody profile in hepatitis C patients undergoing hemodialysis.
Batchoun RG; Al-Najdawi MA; Al-Taamary S
Saudi J Kidney Dis Transpl; 2011 Jul; 22(4):682-8. PubMed ID: 21743211
[TBL] [Abstract][Full Text] [Related]
20. The prevalence of autoantibody and its relationship with genotypes of hepatitis C virus in patients with chronic hepatitis C virus infection.
Kirdar S; Sener AG; Cengİz M; Aydin N
APMIS; 2016 Nov; 124(11):979-984. PubMed ID: 27670736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
